Budesonide/formoterol symbicort manufacturing plant cost?

I don’t have a reliable, public “total manufacturing plant cost” specifically for budesonide/formoterol (Symbicort), because the exact capex varies a lot by:

• Site scope (drug substance API vs finished product only)
• Capacity (e.g., number of canisters/inhalers per year)
• Whether it’s brand-new construction vs expansion/upgrade
• Formulation type (e.g., pressurized metered-dose inhaler vs other dosage form)
• Regulatory/quality systems and local build costs

What I can say (typical industry range)

For a modern pharmaceutical manufacturing facility, ballpark greenfield costs (depending on scope) are often in the range of:

• ~US$100 million to several hundred million for a smaller, single-product or single-step facility
• ~US$500 million to >US$1 billion for a larger integrated site with multiple buildings/lines, utilities, and complex production/QA

But that’s for pharma manufacturing in general, not a confirmed Symbicort-specific plant.

If you tell me what you mean by “manufacturing plant”

I can narrow the estimate. For example:

1. Do you mean API (budesonide/formoterol) manufacture or only finished inhaler filling/packaging?
2. What scale/capacity (inhalers per year) are you assuming?
3. Are you asking about a specific country/site or company (e.g., AstraZeneca, contract manufacturer)?

If you share those details, I’ll give you a more relevant cost range and what drives it.